Chondroitin is most often used to treat temporomandibular joint disorder (TMJ) and osteoarthritis of the low back, and finger, knee, hip, tibiofibular and femotibial joints. Clinical trials using chondroitin in the management of osteoarthritis (OA) show moderate to large statistical effects vs. placebo using a number of different outcome measures. Recent clinical trials have been of superior methodological quality, while some of the older trials have serious methodological flaws, possibly resulting an in an overestimatation of benefits. Most of the randomized control trials are of a relatively short (less than year) to moderate (two years) duration, and long term (beyond three years) efficacy and toxic effects have not been adequately assessed. Significant adverse effects have not been documented. The body of research published to date supports the claim that chondroitin is likely effective in the treatment of osteoarthritis, without well-supported evidence for significant adverse events, toxicity, or interaction with other compounds. There is, however, still controversy in this area.
We are now making large quantities of hydrolized, low molecular weight chondroitin sulfate powder. This hydrolized chondroitin sulfate powder is vastly superior to the non-hydrolized version because of the smaller size of the molecule and its increased bioavailability. It is easier for the body to absorb and make use of the smaller hydrolized chondroitin sulfate molecule as nutritional support for the cartilage matrix.$219.00
Joint Repair Supplements
Federal Laboratories manufactures and processes Health Food Supplements and pharmaceutical raw materials for the wholesale market. Each product is made from start to finish at our facilities in Buffalo, New York. All products are comprehensively tested in our laboratories before leaving our facility. We offer custom pulverizing and analytical testing to meet your specific needs.